Company

TWOCELLS Company, Limited

TWOCELLS Company, Limited is a Hiroshima bio-venture developing regenerative medicine products and automated stem cell culture systems.

About

Founded in 2003 and based in Hiroshima, Japan, TWOCELLS Company, Limited researches, develops and makes regenerative medicine products and automatic cell culturing systems, with a focus on mesenchymal stem cells. Its products include the STK series serum-free culture media and gMSC1, a regenerative therapy for knee cartilage repair. Hiroshima Innovation Network acquired the company in July 2024, and Masaya Matsumoto is its President and CEO as of August 2024.

5Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in